Genmab — December 2012
-
overkommer problemerne med skalering
-
det er ret fedt det her
-
yield & quality talk
-
måske har de fået noget ud af eje en fabrik alligevel
-
duobody vil blive den foretrukne platform for udviklingen af bispecifikke antistoffer i industrien !
-
Så er der Hexabody
-
killing can be induced. tror det virker på mig allerede
-
det ser ud som om der er en ADC killer
-
det virker på alle de gode gamle target
-
cd 19,20,38 og EGFR
-
been there done that
-
vi skal bare have zalu i halen på det
-
duobody de 3 + en large unnamed pharma
-
Så er der Key Takeaways
-
key milestones for 2013
-
positioned for success
-
100 mill usd still to come i ofa
-
i milestones
-
frontline on 6 måneder
-
track record på IND
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind